You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 30, 2025

Drugs in ATC Class G04BA


✉ Email this page to a colleague

« Back to Dashboard


Drugs in ATC Class: G04BA - Acidifiers

TradenameGeneric Name
AMMONIUM CHLORIDE ammonium chloride
AMMONIUM CHLORIDE 0.9% IN NORMAL SALINE ammonium chloride
AMMONIUM CHLORIDE 2.14% ammonium chloride
>Tradename>Generic Name
Showing 1 to 3 of 3 entries

G04BA Market Analysis and Financial Projection

The market dynamics and patent landscape for ATC Class G04BA Acidifiers reveal a niche yet evolving segment within pharmaceuticals and agriculture. Here's a structured analysis:


Market Dynamics

Growth Projections

  • The feed acidifiers market, which shares overlapping compounds with G04BA Acidifiers (e.g., formic acid, lactic acid), is projected to grow from USD 2.58 billion in 2024 to USD 3.39 billion by 2031 (CAGR 5.1%)[1][5]. A separate report forecasts even stronger growth, reaching $4.48 billion by 2029 (CAGR 9.4%)[13].
  • The ammonium chloride market, a key G04BA Acidifier, is estimated to grow from USD 1.77 billion in 2023 to USD 2.25 billion by 2030 (CAGR 3.4%)[16], driven by pharmaceutical and agricultural demand.

Key Drivers

  1. Pharmaceutical Demand: Ammonium chloride (G04BA01) is used as a systemic acidifier for treating metabolic alkalosis and as an expectorant in cough syrups[11][17]. Its role in maintaining acid-base balance in renal and hepatic systems underpins medical applications[3][17].
  2. Regulatory Shifts: The EU ban on in-feed antibiotics has accelerated demand for acidifiers in livestock nutrition, indirectly boosting R&D in related compounds[1][5].
  3. Regional Trends:
    • Asia-Pacific: Dominates ammonium chloride production (50% global supply), driven by agriculture and pharmaceuticals[15][16].
    • North America/Europe: Focus on sustainable practices and advanced livestock farming supports feed acidifier growth[5][13].

Segmentation

  • Feed Acidifiers: Segmented by type (propionic, lactic, formic acids), form (dry/liquid), and livestock (poultry, swine)[13].
  • G04BA Acidifiers: Primarily ammonium chloride (G04BA01) and calcium chloride (G04BA03), used in urological treatments to acidify urine[7][9].

Patent Landscape

Key Innovations

  1. Liquid Acidifier Formulations: Patent CN101120758A details a blend of organic acids (lactic, citric, formic) and salts for enhanced safety and efficacy in animal feed, potentially influencing pharmaceutical applications[4].
  2. GaN Electronics: While unrelated to G04BA, patents in gallium nitride (GaN) technology highlight broader material science advancements that could intersect with acidifier production methods[2][6].
  3. Ammonium Chloride Synthesis: Innovations in sustainable production methods and applications in battery tech (e.g., electrolyte solutions) are emerging, though patents specific to G04BA remain limited[15][16].

Competitive IP Activity

  • Companies like Cree (Wolfspeed) and Intel dominate RF GaN patents, but medical acidifier patents are less centralized[6].
  • EPC and Innoscience are notable in e-mode GaN patents, though their relevance to G04BA is tangential[2].

Regulatory and Safety Considerations

  • Ammonium Chloride: Classified as harmful if swallowed (H302) and a serious eye irritant (H319)[3]. Regulatory scrutiny on nitrogen emissions impacts agricultural use[15].
  • Calcium Chloride: Used in intravenous solutions and urologicals, with patents covering formulations like dialysis fluids[14].

Regional Insights

Region Key Characteristics
Asia-Pacific Largest ammonium chloride producer (China, India); rapid industrialization in feed additives[5][16].
North America Advanced livestock practices and high R&D investment in acidifier blends[5][13].
Europe Stringent environmental regulations drive sustainable acidifier adoption[5][15].

Future Outlook

  • Feed Acidifiers: Microencapsulation and probiotic-acidifier synergies are emerging trends[13].
  • G04BA Acidifiers: Growth tied to urinary health treatments, with potential for novel formulations combining organic acids[4][17].

Highlight: "Liquid acidifier employing organic acid and salt composites effectively overcomes gastrointestinal tissue damage, offering safer utilization of acidifying agents"[4].


Key Takeaways

  • G04BA Acidifiers, particularly ammonium chloride, bridge pharmaceutical and agricultural markets.
  • Patent activity focuses on formulation safety and efficacy, with cross-industry innovations influencing both sectors.
  • Regional regulatory and production dynamics shape market competitiveness.

FAQs

  1. What are G04BA Acidifiers used for?
    Primarily to acidify urine in metabolic disorders and as expectorants[7][17].
  2. How does the feed acidifier market intersect with G04BA?
    Shared compounds (e.g., formic acid) drive parallel R&D in safety and delivery methods[4][13].
  3. Which regions lead in ammonium chloride production?
    Asia-Pacific (notably China) dominates production, while North America/Europe focus on high-value applications[15][16].
  4. What safety concerns exist for ammonium chloride?
    Oral toxicity and eye irritation necessitate strict handling protocols[3].
  5. Are there patents for novel acidifier blends?
    Yes, e.g., CN101120758A combines lactic, citric, and formic acids for improved stability[4].

References

  1. https://www.verifiedmarketresearch.com/product/feed-acidifiers-market/
  2. https://www.knowmade.com/patent-analytics-services/patent-report/gan-electronics-patent-landscape-analysis-2023/
  3. https://pubchem.ncbi.nlm.nih.gov/compound/Ammonium-Chloride
  4. https://patents.google.com/patent/CN101120758A/en
  5. https://www.verifiedmarketresearch.com/product/feed-acidifiers-in-animal-nutrition-market/
  6. https://www.knowmade.com/patent-analytics-services/patent-report/semiconductor-patent-landscape/rf-technologies-patent-landscape/rf-gan-patent-landscape/
  7. https://atcddd.fhi.no/atc_ddd_index/?code=G04BA&showdescription=yes
  8. https://psychedelicalpha.com/data/lsd-patent-tracker
  9. https://www.atccode.com/G04BA
  10. https://patents.google.com/patent/US10081678B2/en
  11. https://www.pharmacompass.com/active-pharmaceutical-ingredients/chlorid-amonny
  12. https://www.globenewswire.com/news-release/2025/02/25/3032292/28124/en/Orthopaedic-Braces-and-Supports-Patent-Landscape-Report-2025-United-States-Leads-with-Over-550-Patents-Filed-Historically-and-230-Currently-In-Progress.html
  13. https://www.thebusinessresearchcompany.com/report/feed-acidifiers-global-market-report
  14. https://www.drugpatentwatch.com/p/generic-api/CALCIUM+CHLORIDE
  15. https://www.globalgrowthinsights.com/market-reports/ammonium-chloride-market-104596
  16. https://www.verifiedmarketresearch.com/product/ammonium-chloride-market/
  17. https://www.pharmacompass.com/chemistry-chemical-name/ammonium-chloride
  18. https://atcddd.fhi.no/atc_ddd_index/?code=G04B&showdescription=yes

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.